Elizabeth McKee Anderson's Insider Trades & SAST Disclosures
Elizabeth McKee Anderson's most recent trade in GSK Plc - ADR was a trade of 42 Ords 0.31p done at an average price of $16.7 . Disclosure was reported to the exchange on Jan. 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Elizabeth McKee Anderson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GSK Plc - ADR | Elizabeth McKee Anderson | Non-Executive Director | Sale or transfer of securities back to the company at price $ 16.67 per share. | 10 Jan 2025 | 42 | 4,360 (0%) | 0% | 16.7 | 700 | Ords 0.31p |
| GSK Plc - ADR | McKee Elizabeth Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 16.90 per share. | 20 Dec 2024 | 544 | 4,318 (0%) | 0% | 16.9 | 9,196 | Ords 0.31p |
| GSK Plc - ADR | Elizabeth McKee Anderson | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.53 per share. | 11 Oct 2024 | 32 | 3,774 (0%) | 0% | 19.5 | 625 | Ords 0.31p |
| GSK Plc - ADR | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.51 per share. | 23 Sep 2024 | 446 | 3,742 (0%) | 0% | 20.5 | 9,146 | Ords 0.31p |
| GSK Plc - ADR | Elizabeth McKee Anderson | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.68 per share. | 12 Jul 2024 | 28 | 3,296 (0%) | 0% | 19.7 | 551 | Ords 0.31p |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 15,955 | 15,955 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,800 | 20,625 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,248 | 20,073 (0%) | 0% | 0 | Common Stock | |
| GSK Plc - ADR | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.38 per share. | 20 Jun 2024 | 450 | 3,268 (0%) | 0% | 20.4 | 9,172 | Ords 0.31p |
| Biomarin Pharmaceutical In... | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,720 | 27,800 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 13,162 | 68,671 (0%) | 0% | - | Common Stock | |
| GSK Plc - ADR | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.50 per share. | 12 Apr 2024 | 22 | 2,818 (0%) | 0% | 20.5 | 451 | Ords 0.31p |
| GSK Plc - ADR | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.95 per share. | 20 Mar 2024 | 438 | 2,796 (0%) | 0% | 21.0 | 9,177 | Ords 0.31p |
| GSK Plc - ADR | Elizabeth McKee Anderson | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.06 per share. | 12 Jan 2024 | 16 | 2,358 (0%) | 0% | 20.1 | 321 | Ords 0.31p |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 5,200 | 15,825 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical In... | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 4,190 | 23,080 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 13,192 | 55,509 (0%) | 0% | - | Common Stock | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 5,200 | 10,625 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical In... | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 4,980 | 18,890 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 14,645 | 42,317 (0%) | 0% | - | Common Stock | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 12,659 | 12,659 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 3,617 | 5,425 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical In... | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 5,120 | 13,910 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 7,558 | 27,672 (0%) | 0% | - | Common Stock | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 13 Oct 2020 | 4,780 | 26,990 (0%) | 0% | 45 | 215,100 | Common Stock |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 13 Oct 2020 | 220 | 31,770 (0%) | 0% | 45 | 9,900 | Common Stock |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 06 Oct 2020 | 5,000 | 31,990 (0%) | 0% | 40 | 200,000 | Common Stock |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 6,329 | 6,329 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 1,808 | 1,808 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical In... | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 4,300 | 8,790 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Elizabeth McKee Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2020 | 8,097 | 20,114 (0%) | 0% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges